[HTML][HTML] Outcomes and laboratory and clinical findings of asthma and allergic patients admitted with Covid-19 in a Spanish University Hospital

…, C Cordobes-Duran, JF Rangel-Mayoral… - Frontiers in …, 2020 - frontiersin.org
Individual susceptibility and clinical outcome of Covid-19 are variable and mortality is also
very variable across countries, being particularly high in Spain. Comorbidities might …

A review on hansen's disease

L Fernández, RM JF, LR FJ - … Oficial de Expresion Cientifica de la …, 2004 - europepmc.org
Hanseńs disease or leprosy is considered a pre-eradicated condition in Spain, with a
prevalence rate of 0.1 cases per 10,000 inhabitants (below 1 case per 10,000 inhabitants …

Neutropenia induced by taxoids and its control with granulocyte colony-stimulating factor

J Luis-Fernández, JF Rangel-Mayoral… - Investigación …, 2005 - europepmc.org
Nowadays, the use of taxoid derivated compounds constitutes one of the main
chemotherapeutic weapons against breast cancer, ovarian cancer and non-microcytic lung …

[HTML][HTML] Estado actual de la investigación en atención farmacéutica

JFR Mayoral, JL Fernández, FJL Rubio - Farmacia Hospitalaria, 2005 - Elsevier
Objetivo Realizar una revisión sistemática de los estudios sobre investigación en atención
farmacéutica entre junio de 1999 y junio de 2004. Método Se utilizaron como fuentes de …

Web 2.0 in the hospital pharmacy

JF Rangel-Mayoral, S Martin-Clavo… - European Journal of …, 2012 - ejhp.bmj.com
Background The term Web 2.0 is associated with web aplications that facilitate information
sharing, user-centred design, interoperability and using the World Wide Web as a …

6ER-022 Knowledge, attitude and practice about pharmaceuticals in the environment among hospital pharmacists in Spain

S Domingo-Echaburu, A Zuriñe, JF Rangel-Mayoral… - 2024 - ejhp.bmj.com
Background and Importance Healthcare professionals need to be more aware of the
negative environmental impact of pharmaceuticals. Hospital pharmacists, in particular, play …

Current research status in pharmaceutical care

RM JF, L Fernández, LR FJ - … Oficial de Expresion Cientifica de la …, 2005 - europepmc.org
Objective A systematic review of studies on pharmaceutical care research from June 1999 to
June 2004 was carried out. Method Medline, Current Contents, Cochrane Library, IDIS, and …

4CPS-388 Telepharmacy during SARS-CoV-2

MDR Rodríguez, RMM Comas, CR Galán… - 2021 - ejhp.bmj.com
Background and importance With the arrival of the global SARS-CoV-2 pandemic, hospital
pharmacy services (HPS) have had to adapt to emerging needs. One of these measures has …

5PSQ-172 Experience with tocilizumab in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

CR Galán, MF Villanueva, DG Vaquero… - 2021 - ejhp.bmj.com
Background and importance Tocilizumab is an immunosuppressive agent which has
demonstrated high efficacy in clinical trials for the treatment of coronavirus because its …

[HTML][HTML] Share this story: RELATED ARTICLES

JFR Mayoral, JL Fernández, FJL Rubio - hospitalpharmacyeurope.com
Discussion A computer program was designed (see Figure 1) with the Microsoft Access (™)
Database Manager. The demographic, clinical and pharmacological variables are displayed …